Goat Milk Infant Formula Comfort Study

NCT ID: NCT06301139

Last Updated: 2024-03-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-05-01

Study Completion Date

2024-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

In this study, the investigators aim to assess that infants with mild symptoms have significantly less (severe) symptoms after 14 days goat milk-based formula use compared to infants using cow's milk-based formula supplemented with probiotic drops.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Anecdotal evidence shows that the use of goat milk-based infant formula decreases discomfort of infants with cow's milk related symptoms. In this randomized controlled pilot study, the effect on comfort during usage of goat-milk based infant formula is studied. Twenty formula fed infants (aged between 6 weeks and 3 months) who experience mild discomfort will receive goat milk-based infant formula (GMF) or cow's mik based infant formula supplemented with probiotics lactobacillus reuteri drops (CMFp). The infants will be assessed by a local paediatricians using the Cow's Milk-related Symptom Score (CoMiSS). This is a fast, non-invasive and easy-to-use and validated questionnaire to assess infant's reaction to proteins found in cow's milk. The higher the score, the more sensitive the child is to cow's milk proteins, the maximum score is 33 points. Infants with a CoMiSS Score between 6 and 12 will be enrolled in this study. It is expected that infants will have a better response to GMF, which will result in a decrease of the CoMiSS Score after a 2 weeks intervention.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Gastrointestinal Diseases Cow's Milk Intolerance

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

randomized controlled pilot study
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Goat milk-based formula

goat milk-based infant formula (GMF)

Group Type EXPERIMENTAL

Goat milk-based infant formula

Intervention Type DIETARY_SUPPLEMENT

Infant formula based on goat milk for 4 weeks at volume depending on the infant

Cow's milk-based formula

cow's milk-based infant formula supplemented with probiotics (CMFp)

Group Type PLACEBO_COMPARATOR

Cow's milk-based infant formula with probiotic drops

Intervention Type DIETARY_SUPPLEMENT

Infant formula based on cow's milk with probiotic Lactobacillus reuteri drops for 4 weeks at volume depending on the infant

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Goat milk-based infant formula

Infant formula based on goat milk for 4 weeks at volume depending on the infant

Intervention Type DIETARY_SUPPLEMENT

Cow's milk-based infant formula with probiotic drops

Infant formula based on cow's milk with probiotic Lactobacillus reuteri drops for 4 weeks at volume depending on the infant

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy full-term infant with birth weight ≥2,500 to ≤4,500 g
* Infant aged between 4 weeks and 3 months at enrolment
* CoMiSS value at baseline between 6 and 12
* Infant is exclusively bottle fed with cow's milk based infant formula at baseline

Exclusion Criteria

* Breastfed infants
* Congenital illness or malformation that may affect infant feeding or normal growth
* Gastrointestinal disorders
* Confirmed cow or goat milk protein allergy or lactose intolerance
* Supplemental feeding
* Readmission to hospital for longer than 3 days for another reason than hyperbilirubinemia prior to enrolment
* Infant participating in another clinical study
Minimum Eligible Age

6 Weeks

Maximum Eligible Age

3 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

HM hospitales

UNKNOWN

Sponsor Role collaborator

Ausnutria Hyproca B.V.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Alejandro López-Escobar, Dr.

Role: PRINCIPAL_INVESTIGATOR

Hospital Universitario General de Villalba

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

HM hospitales

Madrid, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P17-004

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Goat or Cow Milk Based Infant Formula GMS
NCT06312059 RECRUITING PHASE2/PHASE3
Goat vs. Cow Milk Digestive Tolerance
NCT07239856 RECRUITING NA